Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].

Anan G, Suyama T, Takeuchi N, Nakamura K, Sakamoto S, Nihei N, Ichikawa T.

Hinyokika Kiyo. 2013 May;59(5):261-4. Japanese.

2.

Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.

Hayashida Y, Nomata K, Noguchi M, Eguchi J, Koga S, Yamashita S, Hayashi M, Kanatake H.

Urology. 2004 Jun;63(6):1084-8.

PMID:
15183955
3.

Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.

Miyake H, Eto H, Hara S, Okada H, Kamidono S, Hara I.

Int J Urol. 2002 Dec;9(12):677-80.

4.

Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.

Nonomura N, Ono Y, Nozawa M, Fukui T, Harada Y, Nishimura K, Takaha N, Takahara S, Okuyama A.

Eur Urol. 2000 Dec;38(6):701-4;discussion 705.

PMID:
11111187
5.
6.

[Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].

Kita Y, Soda T, Mizuno K, Matsuoka T, Nakanishi S, Asai S, Taoka R, Inoue K, Terai A.

Hinyokika Kiyo. 2011 Jul;57(7):353-7. Japanese.

7.
8.

Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract.

Nishino Y, Yamamoto N, Komeda H, Takahashi Y, Deguchi T.

BJU Int. 2000 May;85(7):799-801.

9.

[Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement : a case report].

Hayashi T, Yamanaka Y, Kinjo T, Katayama K, Kamoto A, Mori N, Yoshioka T.

Hinyokika Kiyo. 2014 Apr;60(4):175-8. Japanese.

10.
11.

Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.

Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M.

J Endourol. 2012 Dec;26(12):1645-50. doi: 10.1089/end.2012.0229. Epub 2012 Oct 9.

PMID:
22834939
12.

Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.

Yokogi H, Wada Y, Mizutani M, Igawa M, Ishibe T.

Br J Urol. 1996 May;77(5):676-9.

PMID:
8689109
13.

Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.

Sharpe JR, Duffy G, Chin JL.

J Urol. 1993 Mar;149(3):457-9; discussion 459-60.

PMID:
8437246
14.
16.

[Efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ of bladder].

Uekado Y, Kohjimoto Y, Iba A, Kikkawa K, Shintani Y, Shinka T.

Hinyokika Kiyo. 2006 Jun;52(6):439-44. Japanese.

PMID:
16848357
17.

Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette-Guérin immunotherapy on the outcome.

Zieger K, Jensen KM.

Scand J Urol Nephrol. 2011 Dec;45(6):411-8. doi: 10.3109/00365599.2011.599335. Epub 2011 Jul 27.

PMID:
21793636
18.

Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ.

Studer UE, Casanova G, Kraft R, Zingg EJ.

J Urol. 1989 Oct;142(4):975-7.

PMID:
2795755
19.

[Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].

Okubo K, Ishitoya S, Maeda H, Suzuki Y, Arai Y.

Nihon Hinyokika Gakkai Zasshi. 1997 Mar;88(3):386-90. Review. Japanese.

20.

Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.

Merz VW, Marth D, Kraft R, Ackermann DK, Zingg EJ, Studer UE.

Br J Urol. 1995 Feb;75(2):180-4.

PMID:
7850322
Items per page

Supplemental Content

Write to the Help Desk